Please log in to determine if you are eligible to purchase PT Programs.
MINIMAL RESIDUAL DISEASE, PML/RARA - MRD2
MRD2
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
PML/RARA 3 Two shipments per year

Program Information

  • Three RNA specimens in sterile water
  • For laboratories diagnosing and monitoring leukemia tumor burden by measuring the quantity of PML/RARA fusion transcripts
  • Ships on dry ice

Shipping Schedule

  • Shipment A: April 20
  • Shipment B: October 5






Customers Who Bought This Item Also Bought
B-ALL MINIMAL RESIDUAL DISEASE
VIEW DETAILS >